Andrew J. Murphy

Executive Vice President, Co-Chief Scientific Officer

Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Co-Chief Scientific Officer	$819,672	—	$2,699,728	$4,049,757	$815,164	$92,798	$8,477,119
2024	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	$803,600	—	$2,699,968	$4,049,729	$783,510	$26,450	$8,363,257
2023	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	$776,250	—	$2,699,284	$4,049,638	$877,939	$26,200	$8,429,311
2022	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	$750,000	—	$2,999,842	$4,499,737	$848,250	$24,700	$9,122,529
2021	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Research	$724,500	—	$2,231,397	$3,347,323	$819,410	$24,200	$7,146,830
2020	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Research	$726,923	—	$5,025,288	$4,335,258	$887,250	$24,195	$10,998,914
2019	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Research	$600,000	—	$4,702,308	$3,526,669	$666,900	$23,470	$9,519,347

Earnings-call appearances

No earnings-call appearances recorded yet.